Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/25/2026 | Q4 | $860.7M | -- | -- | $0.08 | -- |
| 11/03/2025 | Q3 | $810.6M | $850.7M | -$0.10 | $0.16 | -$0.26 |
| 08/06/2025 | Q2 | $774.7M | $811.1M | -$0.01 | $0.05 | -$0.06 |
| 05/01/2025 | Q1 | $688.6M | $706.8M | -$0.54 | -$0.10 | -$0.45 |
| 02/19/2025 | Q4 | $701.5M | $713.4M | -$4.67 | -$0.19 | -$4.48 |
| 11/05/2024 | Q3 | $717M | $708.7M | -$0.21 | -$0.10 | -$0.11 |
| 07/31/2024 | Q2 | $690.1M | $699.3M | -$0.09 | -$0.24 | $0.15 |
| 05/08/2024 | Q1 | $626.8M | $637.5M | -$0.60 | -$0.41 | -$0.20 |
| 02/21/2024 | Q4 | $639.7M | $646.9M | -$0.27 | -$0.36 | $0.08 |
| 11/01/2023 | Q3 | -- | $628.3M | $0.00 | -- | -- |
| 08/01/2023 | Q2 | -- | $622.1M | -$0.45 | -- | -- |
| 05/09/2023 | Q1 | -- | $602.5M | -$0.42 | -- | -- |
| 02/21/2023 | Q4 | -- | $553M | -$0.72 | -- | -- |
| 11/03/2022 | Q3 | -- | $523.1M | -$0.84 | -- | -- |
| 08/02/2022 | Q2 | -- | $521.6M | -$0.94 | -- | -- |
| 04/26/2022 | Q1 | -- | $486.6M | -$1.04 | -- | -- |
| 02/22/2022 | Q4 | -- | $473.8M | -$1.28 | -- | -- |
| 11/02/2021 | Q3 | -- | $456.4M | -$0.97 | -- | -- |
| 07/28/2021 | Q2 | -- | $434.8M | -$1.03 | -- | -- |
| 05/04/2021 | Q1 | -- | $402.1M | -$0.18 | -- | -- |
| 02/16/2021 | Q4 | -- | $466.3M | -$2.67 | -- | -- |
| 10/29/2020 | Q3 | -- | $408.4M | -$1.35 | -- | -- |
| 07/30/2020 | Q2 | -- | $268.9M | -$0.45 | -- | -- |
| 05/06/2020 | Q1 | -- | $347.8M | -$0.91 | -- | -- |
| 02/11/2020 | Q4 | -- | $295.6M | $0.54 | -- | -- |
| 10/29/2019 | Q3 | -- | $218.8M | -$0.31 | -- | -- |
| 07/30/2019 | Q2 | -- | $199.9M | -$0.30 | -- | -- |
| 04/30/2019 | Q1 | -- | $162M | -$0.66 | -- | -- |
| 02/21/2019 | Q4 | -- | $143M | -$0.44 | -- | -- |
| 10/30/2018 | Q3 | -- | $118.3M | -$0.37 | -- | -- |
| 08/01/2018 | Q2 | -- | $102.9M | -$0.30 | -- | -- |
| 04/26/2018 | Q1 | -- | $90.3M | -$0.33 | -- | -- |
| 02/22/2018 | Q4 | -- | $87.4M | -$0.18 | -- | -- |
| 10/31/2017 | Q3 | -- | $72.6M | -$0.23 | -- | -- |
| 07/25/2017 | Q2 | -- | $57.6M | -$0.27 | -- | -- |
| 04/27/2017 | Q1 | -- | $48.4M | -$0.32 | -- | -- |
| 02/21/2017 | Q4 | -- | $35.2M | -$0.34 | -- | -- |
| 10/26/2016 | Q3 | -- | $28.1M | -$0.36 | -- | -- |
| 07/26/2016 | Q2 | -- | $21.2M | -$0.46 | -- | -- |
| 05/03/2016 | Q1 | -- | $14.8M | -$0.49 | -- | -- |
| 02/24/2016 | Q4 | -- | $14.4M | -$0.41 | -- | -- |
EXACT Sciences Corp. reported $850.7M worth of top line sales in its most recent quarter.
EXACT Sciences Corp. announced earnings per share of -$0.10 which represents a miss of analyst forecast a $0.16 per share.
EXACT Sciences Corp. reported $583.9M that represents $3.09 per share over the last quarter.
EXACT Sciences Corp.'s earnings are forecast to decrease from -$5.59 per share to -$0.57 per share next year representing a decrease of -99.99%.
EXACT Sciences Corp.'s next earnings date is February 25, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.